Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

U

University of Regensburg (UR)

Status

Completed

Conditions

Idiopathic Epiretinal Membrane, Cataract

Treatments

Drug: Surgery with and without the aid of Indocyanine Green (ICG)

Study type

Interventional

Funder types

Other

Identifiers

NCT00376857
03123

Details and patient eligibility

About

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months.

Exclusion criteria

  • Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems